Close
ACHEMA MIDDLE EAST 2026

Tweaks In Booster Pitch By Moderna Before Fall Approaches

The question is whether to boost or not to boost. The answer is a resounding yes, as per officials at mRNA expert Moderna. Moderna's...

FDA Expects COVID Vaccines To Become An Annual Occurrence

According to a trio of prominent US Food and Drug Administration experts, the US may need to update its COVID-19 vaccines every year, and...

Despite Global Issues, Indian Pharma Exports Remain Strong

The Government of India recently announced that the pharmaceutical sector had its best-ever export performance in 2021-22, with a phenomenal increase of about $10 billion...

Newer Omicron Types Initiate Their Own Coronavirus Waves

The data is undeniable: COVID-19 instances and hospitalizations are on the rise in the United States, despite patchy documentation. Most states are witnessing an upsurge,...

Pfizer Binds With $22B Paxlovid Plan Amidst Slow Demand

Pfizer officials stated on an earnings call that while Paxlovid's first-quarter sales may seem to be low, there will be plenty more revenues in the...

Teva And Lupin Reach Settlement In AUSTEDO Patent Dispute

Austedo, Teva's tardive dyskinesia (TD) therapy, has great prospects. Now the company only needs to worry about one less generic pharmaceutical presenting a threat...

CDC Suggests Majority of Americans Have COVID-19 Antibodies

According to updated information from the US Centers for Disease Control and Prevention, about 60% of adults plus 75% of children have antibodies suggesting...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...